Cargando…
Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657132/ https://www.ncbi.nlm.nih.gov/pubmed/34885129 http://dx.doi.org/10.3390/cancers13236019 |
_version_ | 1784612440298749952 |
---|---|
author | Beuthien-Baumann, Bettina Sachpekidis, Christos Gnirs, Regula Sedlaczek, Oliver |
author_facet | Beuthien-Baumann, Bettina Sachpekidis, Christos Gnirs, Regula Sedlaczek, Oliver |
author_sort | Beuthien-Baumann, Bettina |
collection | PubMed |
description | SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single visit. ABSTRACT: Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago. Although MRI provides superb soft tissue contrast and functional information without the radiation exposure of CT, PET-MRI is not as widely introduced in oncologic imaging as PET-CT. One reason for this hesitancy lies in the relatively long acquisition times for a PET-MRI scan, if the full diagnostic potential of MRI is exploited. In this review, we discuss the possible advantages of combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single patient visit. |
format | Online Article Text |
id | pubmed-8657132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86571322021-12-10 Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring Beuthien-Baumann, Bettina Sachpekidis, Christos Gnirs, Regula Sedlaczek, Oliver Cancers (Basel) Review SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single visit. ABSTRACT: Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago. Although MRI provides superb soft tissue contrast and functional information without the radiation exposure of CT, PET-MRI is not as widely introduced in oncologic imaging as PET-CT. One reason for this hesitancy lies in the relatively long acquisition times for a PET-MRI scan, if the full diagnostic potential of MRI is exploited. In this review, we discuss the possible advantages of combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single patient visit. MDPI 2021-11-30 /pmc/articles/PMC8657132/ /pubmed/34885129 http://dx.doi.org/10.3390/cancers13236019 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Beuthien-Baumann, Bettina Sachpekidis, Christos Gnirs, Regula Sedlaczek, Oliver Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title | Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title_full | Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title_fullStr | Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title_full_unstemmed | Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title_short | Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring |
title_sort | adapting imaging protocols for pet-ct and pet-mri for immunotherapy monitoring |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657132/ https://www.ncbi.nlm.nih.gov/pubmed/34885129 http://dx.doi.org/10.3390/cancers13236019 |
work_keys_str_mv | AT beuthienbaumannbettina adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring AT sachpekidischristos adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring AT gnirsregula adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring AT sedlaczekoliver adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring |